Herpes Simplex Virus Infection Clinical Trial
Official title:
Pharmacokinetics of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections in Children, Phase II (VALID II)
Valacyclovir has replaced acyclovir in many clinical scenarios. Pharmacokinetic data support the use of oral valacyclovir in children, but practical problems exist in children having to take adult-dose tablets. A formulation with acceptable palatability, good pharmaceutical quality and possibility of flexible dosing is developed. Pharmacokinetic data of this formulation is missing. The present study investigates the pharmacokinetics of valacyclovir oral solution in children by determine the area under the curve (AUC0-12), time above critical concentration (Ccrit), Cmax and Tmax of acyclovir. Secondary, the safety profile of a single dose of valacyclovir oral solution will be determined.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01682109 -
Palatability Testing of a New Paediatric Formulation of Valacyclovir
|
Phase 4 | |
| Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
| Recruiting |
NCT05532540 -
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
|
||
| Recruiting |
NCT05604911 -
Herpes Virus Infections in Kidney Transplant Patients
|
||
| Not yet recruiting |
NCT05664152 -
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
|
N/A | |
| Completed |
NCT01689285 -
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
|
Phase 1 | |
| Recruiting |
NCT04403139 -
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
|
Phase 4 |